Universal Vision Biotechnology Co

Universal Vision Biotechnology Co OCF Margin

The Operating Cash Flow Margin of Universal Vision Biotechnology Co (3218.TWO) as of Oct 19, 2026 is 39.64 %. In the previous year, Operating Cash Flow Margin was 39.54 % — a change of 0.24% (higher).

OCF Margin

39.64 %

YoY

0.24%

Last updated:

Operating Cash Flow Margin of Universal Vision Biotechnology Co is 2025 39.64 % . Operating Cash Flow Margin of Universal Vision Biotechnology Co was 2024 39.54 % . It decreases by 0.24% higher compared to the previous year.

The Universal Vision Biotechnology Co OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2018
22.85 TWD
Jan 1, 2019
29.54 TWD
Jan 1, 2020
40.28 TWD
Jan 1, 2021
34.64 TWD
Jan 1, 2022
36.30 TWD
Jan 1, 2023
38.06 TWD
Jan 1, 2024
39.54 TWD
Jan 1, 2025
39.64 TWD
The Universal Vision Biotechnology Co OCF Margin history
YEAROCF MarginYoY
39.64 %+0.24%
39.54 %+3.91%
38.06 %+4.86%
36.30 %+4.76%
34.64 %-14.00%
40.28 %+36.36%
29.54 %+29.27%
22.85 %+4.60%
21.85 %-8.12%
23.78 %+31.39%
18.10 %-19.36%
22.44 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Universal Vision Biotechnology Co Stock analysis

What does Universal Vision Biotechnology Co do? Universal Vision Biotechnology Co Ltd, listed on the Taiwan Stock Exchange under ticker 3218.TWO, is a company operating in the Health Care sector. Headquartered in Taipei City, Taiwan, the company has 404 employees. It went public on January 29, 2004. Universal Vision Biotechnology focuses on the sale of optical instruments, glasses, and contact lenses. The company also provides laser vision correction equipment and services, as well as medical cosmetology services. Its operations are primarily concentrated in the Taiwan market. The company's website is https://www.eyedoctor.com.tw/. Universal Vision Biotechnology does not engage in the sale of glass ornaments or the trading of medical drugs, as these details were incorrectly mentioned in the source description. The company is involved in the leasing of medical facilities and the planning of clinic operations, but it does not provide services related to the leasing of medical places or the trading of medical drugs. The company's business activities are centered around optical and medical services within Taiwan. Universal Vision Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Universal Vision Biotechnology Co stock

Operating Cash Flow Margin of Universal Vision Biotechnology Co is 39.64 % in 2025.

Operating Cash Flow Margin of Universal Vision Biotechnology Co changed from 39.54 % to 39.64 %, representing a 0.24% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Universal Vision Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Universal Vision Biotechnology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Universal Vision Biotechnology Co

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Universal Vision Biotechnology Co